Trial Profile
Phase I GLIADEL and Continuous Infusion of Intravenous O6-Benzylguanine Trial in Patients With Recurrent Malignant Glioma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 May 2018
Price :
$35
*
At a glance
- Drugs Benzylguanine (Primary) ; Carmustine polifeprosan 20 wafer (Primary)
- Indications Glioma
- Focus Adverse reactions
- 21 Nov 2006 Status changed from in progress to completed.
- 01 Oct 2005 New trial record.